Chimeric molecule for mediating mitochondrial targeted degradation based on autophagy mechanism and application thereof
A technology of mitochondria and chimeric molecules, applied in the direction of hybrid peptides, drug combinations, fusion polypeptides, etc., can solve problems such as inability to directly regulate intracellular mitochondria, side effects, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] 1. Construction of MTL-LIR (Mitochondrial Targeted Degradation Chimeric Molecule) Expression Vector
[0056] In the present invention, four MTL-LIR chimeric molecules were designed: LIR-ActA, NLRX1-LIR, Tom20-LIR and LIR-Mff. where LIR-ActA is composed of LIR and Listeria effector protein ActA 313-338 Amino acid sequence fusion expression, NLRX1-LIR is composed of human NLR family protein NLRX1 1-86 Amino acid sequence and LIR fusion expression, Tom20-LIR is composed of human mitochondrial outer membrane protein Tom20 1-34 The amino acid sequence is fused with LIR, and LIR-Mff is composed of LIR and human mitochondrial fission protein Mff 297-316 Amino acid sequence fusion expression.
[0057] The amino acid sequences of each chimeric molecule are:
[0058] Amino acid sequence of LIR-ActA chimeric molecule (SEQ ID NO: 1):
[0059]
[0060] Amino acid sequence of NLRX1-LIR chimeric molecule (SEQ ID NO:2):
[0061]
[0062] Amino acid sequence of Tom20-LIR chi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com